NIH-funded research R01 grant

Female-specific trigeminal dynorphin role in TMD and migraine overlap

Official title: Female-specific role of trigeminal dynorphin in temporomandibular disorder and its comorbidity

Funded at Texas A&m University Health Science Ctr · NIH-11380671 · Data updated 2026-11-12

This grant studies why women with jaw pain (TMD) often have migraines and looks for female-focused targets to treat both conditions.

More Female research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas A&m University Health Science Ctr
NIH-funded
Lab location1 site (College Station, United States)
Project startAugust 1, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$359,813
NIH project number5R01DE032061-05
Project IDNIH-11380671 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are women with myogenic TMD and migraine, especially those who might benefit from future targeted therapies addressing dynorphin or bradykinin pathways.

Less likely to help

Individuals without TMD or migraine, or those not suitable for future dynorphin/bradykinin-based therapies, may not benefit.

What this research studies

Researchers use an animal model that combines a myogenic jaw pain procedure with a migraine-like trigger to study how sex affects pain. They analyze gene expression to identify dynorphin as a potential female-specific target and test how blocking this molecule in the spinal brain region affects overlapping pain. The work also examines whether blocking the bradykinin receptor can reduce the combined pain in females. The goal is to point toward new therapies that specifically help women who experience both TMD and migraine pain.

Why it matters

Potential benefit: If successful, this work could lead to targeted therapies that reduce pain for women with TMD and migraine overlap.

How similar studies have gone: Earlier work showed female-specific pain mechanisms and responses to bradykinin pathway modulation in this overlapping condition.

Where this research is happening

  • Texas A&m University Health Science Ctr
    College Station, United States
    Active

Researchers

  • Principal investigator: Tao, Feng — Texas A&m University Health Science Ctr
  • Study coordinator: Tao, Feng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.